Leaders Weigh in on how the Fall of Roe Will Affect Biopharma

The U.S. Supreme Court’s decision to overturn Roe v. Wade has had a ripple effect on the biopharmaceutical industry. As the nation reacts, pharma companies must address the changes in demand for reproductive health drugs and services, all while navigating increasingly muddy legal waters.